Spots Global Cancer Trial Database for carcinosarcoma
Every month we try and update this database with for carcinosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | NCT00815945 | Mesenchymal Tum... Carcinosarcoma Leiomyosarcoma | PegLiposomal Do... Carboplatin | 18 Years - | AGO Study Group | |
| Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. | NCT04458597 | Endometrioid Ad... Serous Carcinom... Clear Cell Carc... Carcinosarcoma Dedifferentiate... | Image-guided ad... | 18 Years - | Lawson Health Research Institute | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. | NCT04458597 | Endometrioid Ad... Serous Carcinom... Clear Cell Carc... Carcinosarcoma Dedifferentiate... | Image-guided ad... | 18 Years - | Lawson Health Research Institute | |
| A Study of Nivolumab in Selected Uterine Cancer Patients | NCT03241745 | Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc... | Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors | NCT05949632 | Advanced Solid ... | INCB099280 axitinib | 18 Years - | Incyte Corporation | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | NCT04681248 | Esophageal Neop... Adenocarcinoma ... GastroEsophagea... Squamous Cell C... Gastric Adenoca... Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma Gastric Cancer | DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| ZW25 in Women With Endometrial Cancers | NCT04513665 | Endometrial Can... Carcinosarcoma | ZW25 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes | NCT04171700 | Solid Tumor | Rucaparib | 18 Years - | pharmaand GmbH | |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | NCT04688749 | Melanoma (Skin) Basal Cell Carc... Squamous Cell C... Dysplastic Nevu... Lentigo Maligna Seborrheic Kera... Lichen Planus-L... Carcinosarcoma | Electrical Impe... | 8 Years - 90 Years | Aristotle University Of Thessaloniki | |
| GISAR German Interdisciplinary Sarcoma Registry | NCT04122872 | Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone Carcinosarcoma | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? | NCT03570437 | Carcinosarcoma Endometrial Neo... | Paclitaxel Cediranib Olaparib | 16 Years - | University of Manchester | |
| ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss | NCT04065269 | Gynaecological ... | AZD6738 Olaparib | 18 Years - | Institute of Cancer Research, United Kingdom | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma | NCT05265793 | PD-1 Immunother... VEGFR-TKI Sarcomatoid Car... Carcinosarcoma | Camrelizumab Co... | 18 Years - 75 Years | Fudan University | |
| A Study of Nivolumab in Selected Uterine Cancer Patients | NCT03241745 | Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc... | Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | NCT04688749 | Melanoma (Skin) Basal Cell Carc... Squamous Cell C... Dysplastic Nevu... Lentigo Maligna Seborrheic Kera... Lichen Planus-L... Carcinosarcoma | Electrical Impe... | 8 Years - 90 Years | Aristotle University Of Thessaloniki |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
